卫光生物：拟对下属单采血浆站增资5500万元

Core Viewpoint - The company announced a cash capital increase for its subsidiaries, Wanning Pulp Station and Ankang Pulp Station, to accelerate construction without requiring shareholder approval, indicating a strategic move to enhance operational capacity [1] Group 1: Capital Increase Details - The company approved a cash capital increase of 15 million yuan for Wanning Pulp Station and 40 million yuan for Ankang Pulp Station [1] - Wanning Pulp Station, a wholly-owned subsidiary, will have its registered capital raised to 20 million yuan, maintaining 100% ownership [1] - Ankang Pulp Station, in which the company holds 80% ownership, will see its registered capital increase to 11.9742 million yuan, with the company's ownership rising to 91.65% after the capital increase [1] Group 2: Strategic Implications - The capital increase aims to expedite the construction of the pulp stations, reflecting the company's commitment to enhancing its operational capabilities [1] - The capital increase does not affect the scope of the consolidated financial statements or the normal operations of the company, indicating stability in its financial structure [1]